Portugal. From SACiUCI to InfAUCI. Sepsis epidemiology: an update. You re only given a little spark of madness. You mustn t lose it.

Similar documents
Sepsis the clinical syndrome

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

Guess or get it right?

Enhanced EARS-Net Surveillance 2017 First Half

Healthcare-associated infections acquired in intensive care units

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Supplementary Appendix

Nosocomial infections surveillance in RIPAS Hospital

Polmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège

Supplementary Appendix

Infections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital

Guidelines. 14 Nov Marc Bonten

Herpes virus reactivation in the ICU. M. Ieven BVIKM

Online Supplement for:

Teresa Cardoso 1 *, Armando Teixeira-Pinto 2, Pedro Pereira Rodrigues 3, Irene Aragão 4, Altamiro Costa- Pereira 5, António E. Sarmento 6.

The Role of POCT in Management of Infectious Disease in the Critical Care Setting

Terapia della candidiasi addomaniale

Top 5 papers in clinical mycology

Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study

THE INCREASING IMPORTANCE OF HEALTH CARE-ASSOCIATED INFECTIVE ENDOCARDITIS

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA

Enterobacter aerogenes

Cristina Granja 1,2 *, Pedro Póvoa 3,4, Cristina Lobo 2, Armando Teixeira-Pinto 1,2,5, António Carneiro 6, Altamiro Costa-Pereira 1,2.

Community Acquired & Nosocomial Pneumonias

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine

La terapia empirica nelle infezioni micotiche

Pneumonia Severity Scores:

HOSPITAL INFECTION CONTROL

Sepsi: nuove definizioni, approccio diagnostico e terapia

Pseudomonas aeruginosa

Nosocomial Infection in a Pediatric Intensive Care Unit in a Developing Country

Supplementary appendix

Supplementary Materials to the Manuscript: Polymorphisms in TNF-α Increase Susceptibility to

Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis

Outcome of patients with hematologic malignancy admitted to the ICU

Long-term impact & outcomes of neurological critical illness

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital

ARDS during Neutropenia. D Mokart DAR IPC GRRRRROH 2010

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM

Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates

Infected cardiac-implantable electronic devices: diagnosis, and treatment

Influenza-Associated Pediatric Deaths Case Report Form

VAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland.

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

CURRENT GUIDELINES FOR SEPSIS MANAGEMENT

Severe and Tertiary Peritonitis

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES

Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection

What other beneficial effects might GLN exert in critical illness??

Lessons from recent studies. João Gonçalves Pereira UCIP DALI

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

No conflicts of interest to disclose

Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery

THE USE OF THE PENICILLINASE-RESISTANT

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

MAKING SENSE OF IT ALL AUGUST 17

Yi-Wei Tang, MD, PhD, F(AAM), FIDSA Professor of Pathology and Medicine Director, Molecular Infectious Diseases Laboratory

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium

BACTERIOLOGY OF POSTOPERATIVE PNEUMONIA EOLE STUDY Dupont H ICM 2003, 29,

Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D.

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Supplementary Online Content

Clinical Science. Vesna Degoricija, Mirella Sharma, Ante Legac 1, Marina Gradišer 2, Siniša Šefer, Željko Vučičević

Inadequate Empiric Antibiotic Therapy among Canadian. Hospitalized Solid-Organ Transplant Patients: Incidence and Impact on Hospital Mortality

Index. Note: Page numbers of article titles are in boldface type.

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece

NIV in hypoxemic patients

A study on common pathogens associated with nosocomial infections and their antibiotic sensitivity

A Two-Year Analysis of Risk Factors and Outcome in Patients with Bloodstream Infection

Urinary tract infection. Mohamed Ahmed Fouad Lecturer of pediatrics Jazan faculty of medicine

Supplementary Online Content

Pneumonia Community-Acquired Healthcare-Associated

Augmented Renal Clearance: Let s Get the Discussion Flowing

PATIENT DEMOGRAPHICS. Surname. Given name. Pacific Islander (non-maori) ADMISSION DETAILS

PROGRAM. 07 MARCH 16 Sepsis 3.0

SEPSIS AND SEPTICEMIA St. Charles Bend / Dec. 18, 2015

Increased female mortality after ICU admission and its potential causes.

Steroid in Paediatric Sepsis. Dr Pon Kah Min Hospital Pulau Pinang

Contraindications to time critical surgery; when not to proceed from the perspective of: The Physician A/Prof Peter Morley

Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection

Sepsis Treatment: Early Identification Remains the Key Issue

Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit

Fungal Infections in Patients with Severe Acute Pancreatitis and the Use of Prophylactic Therapy

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency

Biomarkers in sepsis: Utility in critical care

Pneumonia in the Hospitalized

The characteristics of bacterial pathogens in cases of children with respiratory tract infection in Eastern area.

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice

Ankit Sakhuja, Gagan Kumar, Shipra Gupta, Tarun Mittal, Amit Taneja, and Rahul S. Nanchal

Outpatient treatment in women with acute pyelonephritis after visiting emergency department

Abstract. Introduction

Sniffs and Sneezes can Spread Diseases: Year- Round Protection. Jim Gauthier, MLT, CIC Senior Clinical Advisor, Infection Prevention

Index. Note: Page numbers of article titles are in boldface type.

Transcription:

Sepsis epidemiology: an update Portugal João Gonçalves Pereira ICU director Vila Franca Xira Hospital From SACiUCI to InfAUCI You re only given a little spark of madness. You mustn t lose it. Robin Williams

Cardoso, Crit Care, 2010, 14: R83 2004-2005 17 ICUs Identification of 897 (22%) patients with community-acquired sepsis 2009-2010 15 ICUs Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308 Identification of 1556 (44%) patients with sepsis on ICU admission

Community acquired sepsis admitted to the ICU N 4142 3572 Age (years) 60 (±18) 61 (±17) Infection on admission to the ICU SAPS II 44 (±18) 45 (±18) SOFA 7.4 (±3) 7 [1-15] Charlson Score Lenght of stay (ICU) 5 [0-15] 6 [2-21] 6 [2-34] Lenght of stay (H) 19 [3-86] 19 [3-86] Year 2005 2010

Infection Incidence Infection Infection 22% Community 30% 56% N=4142 78% Hospital 14% Cardoso, Crit Care, 2010, 14: R83 N=3572 Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308

Infection Incidence Infection Infection 14% 78% 22% 17% 5% 56% 30% 24% 6% Community Community N=4142 Health Care associated N=3572 Health Care associated Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308 HCA/CAI 23% (), 20% ()

Infection Source 60 40 20 0 Roughly 60% of infections were from the pulmonary tract (either pneumonia or tracheobronchitis)

data Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308

data Positive microbiology 40.5% Appropriate antibiotic 81.6% Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308

Isolated Microrganisms 60 50 40 30 20 10 0 Gram + Gram - Fungi Virus Others

Isolated Resistant Microrganisms Acinectobacter spp 14 1 12 Pseudomonas spp 17 10 Klebsiella spp 38 Staphylococcus aureus MR 16 (20%) 8 6 4 2 0 CAI HCA Hospital Oxacillin resistance CAI 31.9% HCA 60.7% H 67.9%

Sepsis Stratification on ICU admission 60 50 40 30 20 10 0 Sepsis Sepsis Stratification Severe sepsis Septic Shock Length of Stay ICU 9 (10) vs 8 (36) Hospital 19 (9) vs 22 (86)

Impact of Infection on mortality No infection Infection ICU mortality 23% 30% <0.001 Hospital mortality 32% 38% 0.003 No infection Infection ICU mortality 19% 27% <0.001 Hospital mortality 26% 38% <0.001 Gonçalves-Pereira, Clin Microbiol Infect 2014, 12: 1308

Impact of Infection on mortality No infection Infection ICU mortality 23% 30% <0.001 Hospital mortality 32% 38% 0.003 160 patients with Positive Blood Cultures Fungal infections OR 2.8 OR 1.7 HCA infection OR 1.6 * * * * * * * * * * * * Inadequate antibiotics OR 1.4 * Granja, Plos One 2013, 8: e53885 Gonçalves-Pereira, Clin Microbiol Infection, 2013, 19: 242 *p<0.05

Seasonal distribution of infections 300 250 200 150 100 50 0 50 Spring Summer Fall Winter 500 450 400 350 300 250 200 150 100 Respiratory Neurologic Urologic Intra-Abdominal Skin and soft tissues Ginecologic-obstetric Endovascular Other 0 Other Urological Skin Bacteremia Abdominal Pneumonia

Seasonal distribution of infections 500 450 400 350 300 250 200 150 100 50 0 Other Urological Skin Bacteremia Abdominal Pneumonia 600 500 400 300 200 Pneumonia 31.6% 37.8% Abdominal 41.5% 37.1% Death Survivors 100 0 Spring Summer Fall Winter Spring Summer Fall Winter

CRP ratio Process of Care Early appropriate antibiotic therapy Mortality and Time of Antibiotic Therapy (<3h/ 3h) N <3h 3h OR 95% CI P Total 707 24.2% 32.6% 1.52 1.05-2.20 0.026 Documented Infection 364 24.3% 37.9% 1.90 1.04-3.45 0.035 Septic Shock 452 36.7% 45.4% 1.433 0.91-2.27 0.124 Antibiotic adequacy 81.6% 1,2 1,1 1 0,9 0,8 0,7 0,6 0,5 1 2 3 4 5 Day Gonçalves-Pereira, ATS 2011 P B104 <3h 3-12h >12h

Process of Care Early appropriate antibiotic therapy 90% 80% 70% 60% 50% 40% 30% 20% 10% Time until antibiotic therapy 2.30h 0% Community Health Care Hospital <3h >3h 75% Appropriate Inappropriate 40% 20% 20,1% 19,8% 50% 25% 26,7% 50% 0% Mortality 0% ICU Mortality OR 2.75 (1.89-3.99)

Admission delay Process of Care 3±6 days The mortality rate was similar in patients with CAI admitted directly to the ICU or first to the ward (35.9% vs. 35.1%, p=0.78) 2±2 days The mortality rate was similar in those admitted directly to the ICU or first to the ward (32% vs. 29%) An increase in CV failure was noted, from 8.6% at D0 to 51% at admission to the ICU Povoa, Crit Care Med, 2009, 37: 410

Process of Care Microbiology Only 48.3% documented infections (50.9% of hospital-acquired infections) Blood cultures were collected in 48% of CAI patients Collection was associated with a decrease in mortality OR 0.57 (0.33-0.97) Cardoso, Crit Care, 2010, 14: R83 Post ICU Mortality 11.4% (infected) vs. 11.4% (non infected) 14.2% (infected) vs. 9.6% (non infected), p<0.001

Process of Care ICU acquired infection In the overall population an ICU acquired infection was associated with an increase in mortality OR 1.55 (1.32-1.82) In the infected population a new ICU acquired infection increased mortality OR 2.16 (1.74-2.67) Gonçalves-Pereira, Clin Microbiol Infection, 2013, 19: 242

Conclusions Population characteristics were similar in (2005) and (2010) studies Infected patients are roughly 40% of all ICU admissions and 50% presented in septic shock Health care associated infections are frequent and commonly present resistant microrganisms Changes in the process of care may help to improve the outcome of the infected population